Table 1.
Comparison of general conditions, duration of surgery and anaesthesia, and intraoperative cardiovascular active drug dosage.
| General analgesia (n = 37) | TPVB (n = 36) | TPVB + S-ketamine (n = 37) | Group N (n = 40) | P Value | |
|---|---|---|---|---|---|
| Age (y) | 56.46 ± 6.07 | 58.81 ± 5.58 | 57.14 ± 5.94 | 57.62 ± 4.78 | 0.527 |
| Sex (M/F) | 17/20 | 15/21 | 19/17 | 22/18 | 0.628 |
| Weight (kg) | 63.65 ± 7.04 | 63.86 ± 8.21 | 66.57 ± 7.24 | 69.13 ± 6.43 | 0.237 |
| BMI (kg/m2) | 22.56 ± 1.46 | 22.31 ± 1.86 | 22.81 ± 1.65 | 23.17 ± 1.96 | 0.453 |
| ASA (I/II/III) | 15/18/4 | 12/20/4 | 13/21/3 | 12/25/3 | 0.822 |
| Duration of analgesia | 183.78 ± 60.93 | 189.72 ± 60.01 | 182.97 ± 62.72 | … | 0.877 |
| Duration of surgery | 147.16 ± 54.18 | 155.14 ± 57.58 | 145.54 ± 56.23 | … | 0.737 |
| Atropine dosage | 0（0-0） | 0（0-0） | 0（0-0） | … | 0.477 |
| Ephedrine dosage | 0（0–1.5） | 0（0–6） | 0（0–6） | … | 0.497 |
ASA, American Society of Anaesthesiologists; BMI, body mass index; TPVB, thoracic paravertebral block.
Data are expressed as mean ± standard deviation or numbers (percentages).